Evidence map›Paper›PMID 34035282›Full record

ArticleNature communications2021

Non-productive angiogenesis disassembles Aß plaque-associated blood vessels.

Maria I Alvarez-Vergara, Alicia E Rosales-Nieves, Rosana March-Diaz, Guiomar Rodriguez-Perinan, Nieves Lara-Ureña, Clara Ortega-de San Luis, Manuel A Sanchez-Garcia, Miguel Martin-Bornez, Pedro Gómez-Gálvez, Pablo Vicente-Munuera and 20 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. New perspectives on VEGF signalling in Alzheimer's disease.Brain pathology (Zurich, Switzerland) · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Neuroinflammation in Alzheimer disease.Nature reviews. Immunology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 9 institutions in 4 countries.

Maria I Alvarez-Vergara *Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.
Alicia E Rosales-Nieves *Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.ORCID 0000-0001-9119-1604
Rosana March-DiazInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.
Guiomar Rodriguez-PerinanInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.
Nieves Lara-UreñaInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.
Clara Ortega-de San LuisInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.ORCID 0000-0002-8365-2762
Manuel A Sanchez-GarciaInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.ORCID 0000-0003-3914-2332
Miguel Martin-BornezInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.
Pedro Gómez-GálvezInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.ORCID 0000-0002-0509-227X
Pablo Vicente-MunueraInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.ORCID 0000-0001-5402-7637
Beatriz Fernandez-GomezGrupo de Neurobiología del Desarrollo-GNDe, Instituto Cajal-CSIC, Madrid, Spain.
Miguel A MarchenaGrupo de Neurobiología del Desarrollo-GNDe, Instituto Cajal-CSIC, Madrid, Spain.
Andrea S Bullones-BolanosInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.
Jose C DavilaCentro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Rocio Gonzalez-MartinezInstituto de Neurociencias de Alicante, Consejo Superior de Investigaciones Científicas-Universidad Miguel Hernández (CSIC-UMH), Alicante, Spain.
Jose L Trillo-ContrerasInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.
Ana C Sanchez-HidalgoInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.
Raquel Del ToroInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.ORCID 0000-0002-1379-7990
Francisco G SchollInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.
Eloisa HerreraInstituto de Neurociencias de Alicante, Consejo Superior de Investigaciones Científicas-Universidad Miguel Hernández (CSIC-UMH), Alicante, Spain.ORCID 0000-0001-9525-5441
Martin TrepelAugsburg Medical Center, Department of Hematology and Oncology, Augsburg, Germany.
Jakob KörbelinSection of Pneumology, Department of Oncology, Hematology and Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-5435-7182
Luis M EscuderoInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.ORCID 0000-0001-8030-1820
Javier VilladiegoInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.ORCID 0000-0003-2131-9013
Miriam EchevarriaInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.ORCID 0000-0002-4758-9428
Fernando de CastroGrupo de Neurobiología del Desarrollo-GNDe, Instituto Cajal-CSIC, Madrid, Spain.ORCID 0000-0002-7018-8032
Antonia GutierrezCentro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.ORCID 0000-0002-6264-6152
Alberto RabanoFundacion CIEN, Madrid, Spain.
Javier VitoricaInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.ORCID 0000-0002-0641-7902
Alberto PascualInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain. apascual-ibis@us.es.ORCID 0000-0001-5459-6207
Instituto de Biomedicina de Sevilla · ESBiomedical Research Networking Center on Neurodegenerative Diseases · ESInstituto Cajal · ESConsejo Superior de Investigaciones Científicas · ESCentro de Investigación en Red en Enfermedades Cardiovasculares · ESFundacion Centro De Investigacion De Enfermedades Neurologicas · ESTrinity College Dublin · IEUniversität Hamburg · DEUniversity Hospital Augsburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human Alzheimer's disease (AD) brain accumulates angiogenic markers but paradoxically, the cerebral microvasculature is reduced around Aß plaques. Here we demonstrate that angiogenesis is started near Aß plaques in both AD mouse models and human AD samples. However, endothelial cells express the molecular signature of non-productive angiogenesis (NPA) and accumulate, around Aß plaques, a tip cell marker and IB4 reactive vascular anomalies with reduced NOTCH activity. Notably, NPA induction by endothelial loss of presenilin, whose mutations cause familial AD and which activity has been shown to decrease with age, produced a similar vascular phenotype in the absence of Aß pathology. We also show that Aß plaque-associated NPA locally disassembles blood vessels, leaving behind vascular scars, and that microglial phagocytosis contributes to the local loss of endothelial cells. These results define the role of NPA and microglia in local blood vessel disassembly and highlight the vascular component of presenilin loss of function in AD.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsBlood VesselsBrainDisease Models, AnimalEndothelial CellsFemaleGene Expression ProfilingHumansMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicNeovascularization, PathologicPlaque, AmyloidAmyloid beta-Peptides

Identifiers

PMID34035282
PMCPMC8149638
OpenAlexW3164985684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.